Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: A case report  by Furumoto, Katsuyoshi et al.
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INTRODUCTION:  Skeletal  muscle  metastases  from  carcinomas,  especially  to intercostal  muscles,  are  rare.
Most  metastatic  chest  wall  tumors  from  hepatocellular  carcinoma  (HCC)  result  from  disseminations
through  needle  tracts  of intrahepatic  HCC  treatments.
PRESENTATION OF  CASE:  We  report  the  case  of  a 65-year-old  man  with  chronic  viral  hepatitis  B  whose
intrahepatic  lesions  were  stabilized  by  repeated  radiofrequency  ablations  and transcatheter  arterial
chemoembolization.  Follow-up  computed  tomography  demonstrated  a well-enhanced  mass  in the  right
chest  wall.  Because  -fetoprotein  and  des--carboxy  prothrombin  levels  were  elevated  and  no other
tumors  were  detected,  we  diagnosed  the mass  as  an  extrahepatic  metastasis  from  the  HCC  and  resected
it  along  with  the  surrounding  ribs.  There  was  no involvement  of  the  bone,  pleura,  and  lung.
DISCUSSION: The  tumor  was  microscopically  diagnosed  as  an intercostal  muscle  tumor  metastasized  from
HCC,  which  has  not  been  documented  previously.  The  resection  rate  of extrahepatic  tumors  of  HCC  is
low  in literature.  No  other  apparent  extrahepatic  recurrence  has  been  observed  for more  than  20  months
after  the  surgery.
CONCLUSION:  We  report  the  case  of HCC  patient  who  underwent  surgical  resection  of an intercostal
muscle  tumor  that  had metastasized  from  HCC.  Pathological  examination  of  the  tumor  revealed  the
tumor  cells in the blood  vessels,  and  we  speculate  it hematogeneous  metastasis.
 
.. Introduction
Chest wall masses primarily result from infection or tumors,1
nd malignant chest wall tumors, especially those metastasized
rom hepatocellular carcinomas (HCCs), are uncommon. HCC is an
ggressive tumor, the treatment of which depends on the extent of
ts spread; however, no speciﬁc guidelines exist for the treatment
f extrahepatic metastatic lesions. We  report here a case of an iso-
ated metastasis in the 7th intercostal muscle of the right chest
all, which was  detected after repeated radiofrequency ablations
RFA) and transcatheter arterial chemoembolization (TACE) for the
ntrahepatic HCC. Metastasis of any type of carcinoma to skeletal
uscle is rare, and no previous reports have described the removal
f intercostal muscle tumors metastasizing from HCC.∗ Corresponding author at: Department of Surgery, Kishiwada City Hospital, 1001
akuhara-cho, Kishiwada-shi, Osaka 596-8501, Japan. Tel.: +81 72 445 1000;
ax: +81 72 441 8812.
E-mail  address: furupichi@uu.em-net.ne.jp (K. Furumoto).
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2. Presentation of case
A 65-year-old man  with chronic viral hepatitis B and liver cir-
rhosis was  referred to our outpatient clinic 3 years back for the
treatment of a liver tumor diagnosed as HCC. The tumor was
about 2 cm in diameter and was  located in segment 8 (Fig. 1a).
It was treated by RFA and TACE because the patient refused
to undergo hepatectomy. Approximately 2 years later, a new
lesion was  detected in segment 5 (Fig. 1b). RFA was performed
7 times and TACE once and the intrahepatic tumors were con-
trolled (Fig. 1c and d). Despite treatment, serum -fetoprotein
(AFP) and des--carboxy prothrombin (PIVKA-II) levels increased
to 47.4 ng/ml (normal range: ∼7 ng/ml) and 600 mAU/ml (nor-
mal range: ∼40 mAU/ml), respectively, and computed tomography
(CT) examination revealed a right chest wall mass approximately
2.9 × 1.9 cm in size. It was  heterogeneous and weakly enhanced in
both early (arterial) and late phases (Fig. 2). The tumor was  located
away from the needle tract area of prior RFA treatment, and there
was no pleural or pulmonary involvement. Although the patient
Open access under CC BY-NC-ND licensedid not notice the mass, physical examination revealed a hard,
less mobile, and painless mass about 3 cm in diameter. No other
lesions were detected on CT. We  diagnosed the tumor as a soli-
tary extrahepatic metastasis of the HCC and performed a radical
 BY-NC-ND license.
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Fig. 1. Contrast-enhanced CT showed a well-enhanced tumor in segment 8 in an early phase 3 years ago (a) and approximately 2 years later, a new lesion in segment 5 (b).
Both  were controlled with treated by repeated RFA and TACE (c, d). Arrow: ablated lesion. *: gallbladder.
Fig. 2. Contrast-enhanced CT revealed a right chest wall mass that was  heterogeneous and weakly enhanced in both early (arterial) (a, c) and late (b) phases.
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tig. 3. A radical resection of the tumor along with a part of the adjacent 7th and 
erratus anterior muscle (arrow) (a), lung, or pleura (b). The 8 × 5 cm chest wall def
esection of the tumor along with a part of the adjacent 7th and 8th
ibs to ensure a safety margin. The tumor was solid and hard, and
he serratus anterior muscle, lung, and pleura were not involved.
he 8 × 5 cm chest wall defect was closed with a prolene mesh
Fig. 3). The resected specimen was well encapsulated and mea-
ured 3.5 × 1.8 × 2.5 cm in size. The cut surface of the tumor was
ellowish with septa (Fig. 4). Pathological examination revealed the
resence of HCC in the intercostal muscle without inﬁltration into
he surrounding bones. Cancer cells were observed in the vessels,
uggesting that the tumor metastasized via a hematogenous route
Fig. 5). Postoperative serum AFP and PIVKA-II levels decreased to
ithin the normal range. Ten months later, these tumor markers
ncreased and intrahepatic recurrence was detected on CT. TACE
as performed and both AFP and PIVKA-II levels decreased again.
o other extrahepatic recurrence has been observed in the chest
all or elsewhere in the body for more than 20 months.
.  Discussion
HCC is an aggressive tumor, the treatment of which depends
n the extent of its spread. Extrahepatic metastases of HCC are
ot rare, and have an incidence rate of 13.5–37%.2–5 There is no
onsensus on the anticancer therapy that should be provided to
atients with extrahepatic metastases of HCC. The algorithm for
CC therapy in the Clinical Practice Guidelines for Hepatocellu-ar Carcinoma in The Japan Society of Hepatology 2009 update
lso does not suggest a clear recommendation for these patients.
e present the case of a patient with intrahepatic tumors con-
rolled by repeated RFA, whose metastatic chest wall tumor wass was performed. The tumor (arrowheads) was solid and hard, and free from the
 was  closed with a prolene mesh (d).
successfully  resected. Pathological examination revealed that the
tumor was  an intercostal muscle metastasis of the HCC.
The  most common sites of extrahepatic involvement are the
lungs, lymph nodes, bones, and adrenal glands, and the chest wall
is a rare site of HCC metastasis; in a report by Katyal et al., only
6 of 148 HCC patients had extrahepatic lesions in chest wall.2 A
few cases of chest wall tumors have been deﬁned as rib metastases
from HCC6,7; however, it is very difﬁcult to determine whether a
chest wall metastatic tumor is muscular or osseous (rib) metastasis,
especially when it is large. The present case is noteworthy because
the intercostal muscle metastasis was  clearly diagnosed.
Metastasis to intercostal muscles from malignant tumors is
very rare, and only 1 case of metastasis of a squamous cell carci-
noma from the uterine cervix has been reported.8 An online search
on PubMed using the keywords “hepatocellular carcinoma” and
“intercostal (muscle) metastasis” showed that all intercostal mus-
cle lesions were reported to be the result of disseminations through
needle tracts from previous RFA therapy, percutaneous ethanol
injection therapy, or biopsy for intrahepatic tumors, and to our
knowledge, this is the ﬁrst report of hematogenous metastasis of
HCC to an intercostal muscle. Needle tract implantation due to RFA
could be ruled out in this case because of the absence of pulmonary
or pleural involvement and the clear existence of lung between the
tumor and liver. Another possible origin of the tumor was ectopic
liver tissue or a hepatoid adenocarcinoma; however, these were
ruled out on the basis of the pathological ﬁndings. No normal liver
tissue or adenocarcinoma was observed. Almost all ectopic HCC had
no mother liver HCC,9 which also suggested that the tumor in our
case was different from the ectopic HCC.
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Fig. 4. The resected specimen was well encapsulated and measured of 3.5 × 1.8 × 2.5 cm in size (a). There was no apparent invasion to the pleura (b). The cut surface of the
tumor was yellowish with septa (c).
Fig. 5. Pathological examination revealed the presence of HCC in the intercostal muscle (*) (a, b) without inﬁltration into the surrounding bones (**) or involvement of
collagen ﬁber (c). Cancer cell emboli (arrows) were observed in the vessels (d).
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Skeletal muscle is also a rare site of HCC metastases, with a
eported incidence rate of 0–1.5%.3–5 This rarity, despite the abun-
ant blood supply, may  be attributed to the contractile properties
f muscle, the local acidic environment resulting from the accu-
ulation of lactic acid and other metabolites,10 and the presence of
umor suppressors11 or lymphocytes.12 In previous reports, tumors
hat most frequently metastasized to skeletal muscle were of pul-
onary origin,13 and the skeletal muscles most frequently involved
n metastasis were the diaphragm (67.8%) and the iliopsoas muscle
29.4%).10
Metastasis of HCC occurs through intrahepatic blood vessels,
ymphatic permeation, or direct inﬁltration. Pathological examina-
ion of the resected tumor in our case showed apparent vascular
ancer cell emboli; therefore, we speculated that the tumor cells
eached the chest wall hematogenously.
When intensive therapies such as RFA and TACE result in remis-
ion of intrahepatic disease, surgical resection of extrahepatic
etastases is the only means of controlling the disease and pro-
onging life, despite the availability of the multi-targeted kinase
nhibitor, sorafenib. Although the resection rate of extrahepatic
esions is very low (2–6.4%),3–5 the survival rates of patients who
nderwent surgical resection of extrahepatic metastases were sig-
iﬁcantly higher than those of patients who did not.14 When only 1
r 2 extrahepatic tumors are present, surgical resection is beneﬁcial
or HCC patients who have good hepatic reserve, good perfor-
ance status, controlled intrahepatic disease, and no portal vein
nvasion.3,14
We  have reported here a rare skeletal muscle metastasis in
he chest wall from HCC, which was surgically removed. Although
he patient underwent another round of TACE for the intrahepatic
ecurrence after the resection, no other extrahepatic recurrence has
een observed in the chest wall or elsewhere in the body for more
han 20 months.
.  Conclusion
We  report a case of skeletal intercostal muscle metastasis in
he chest wall from HCC. This was a rare metastasis and could be
urgically removed. The patient is alive without other extrahepatic
ecurrence for more than 20 months after the surgery.onﬂict of interest
None.
1
1
pen Access
his  article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
urgery Case Reports 3 (2012) 322– 326
Funding
None.
Ethical approval
Written informed consent was  obtained from the patient for
publication of this case report.
Author contributions
KF  has organized this work and written the manuscript. All
authors reviewed the manuscript and approved the ﬁnal version.
References
1. Simpson L, Hanson M,  Sheagren JN, Mallow J, Popalla S. An anterior chest wall
mass. American Journal of Medicine 2003;115:743–4.
2.  Katyal S, Oliver 3rd JH, Peterson MS,  Ferris JV, Carr BS, Baron RL. Extrahepatic
metastases  of hepatocellular carcinoma. Radiology 2000;216:698–703.
3. Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, et al. Clinical
features  and prognosis of patients with extrahepatic metastases from hepato-
cellular carcinoma. World Journal of Gastroenterology 2007;13:414–20.
4. Natsuizaka M,  Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, et al. Clinical
features  of hepatocellular carcinoma with extrahepatic metastases. Journal of
Gastroenterology and Hepatology 2005;20:1781–7.
5.  Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M,  Wada H, et al. Patterns
and  clinicopathologic features of extrahepatic recurrence of hepatocellular car-
cinoma after curative resection. Surgery 2007;141:196–202.
6.  Hofmann HS, Spillner J, Hammer A, Diez C. A solitary chest wall metastasis from
unknown primary hepatocellular carcinoma. European Journal of Gastroenterol-
ogy and Hepatology 2003;15:557–9.
7. Coban S, Yüksel O, Köklü S, Ceyhan K, Baykara M,  Dökmeci A. Atypical presen-
tation  of hepatocellular carcinoma: a mass on the left thoracic wall. BMC  Cancer
2004;4:89.
8.  Ferrandina G, Salutari V, Testa A, Zannoni GF, Petrillo M, Scambia G. Recurrence
in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case
report and review of the literature. BMC  Cancer 2006;6:169.
9. Kubota K, Kita J, Rokkaku K, Iwasaki Y, Sawada T, Imura J, et al. Ectopic hep-
atocellular  carcinoma arising from pancreas: a case report and review of the
literature. World Journal of Gastroenterology 2007;13:4270–3.
0. Acinas Garcia O, Fernandez FA, Satue EG, Buelta L, Val-Bernal JF. Metasta-
sis  of malignant neoplasms to skeletal muscle. Revista Espanola de Oncologia
1984;31:57–67.
1.  Bar-Yehuda S, Barer F, Volfsson L, Fishman P. Resistance of muscle to tumor
metastases:  a role for a3 adenosine receptor agonists. Neoplasia 2001;3:125–31.
2. Zetter BR. The cellular basis of site-speciﬁc tumor metastasis. New England Jour-
nal of Medicine 1990;322:605–12.
3. Koike Y, Hatori M,  Kokubun S. Skeletal muscle metastasis secondary to cancer –
a report of seven cases. Upsala Journal of Medical Sciences 2005;110:75–83.
4. Chan KM, Yu MC,  Wu  TJ, Lee CF, Chen TC, Lee WC,  et al. Efﬁcacy of surgical
resection  in management of isolated extrahepatic metastases of hepatocellular
carcinoma.  World Journal of Gastroenterology 2009;15:5481–8.uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
